AKT1 and melanoma: Wang et al. investigated the functional significance of TUSC3, demonstrating its inhibitory effects on melanoma cells and its ability to induce ER stress through inhibition of the AKT/GSK3-β/β-catenin pathway, suggesting that TUSC3 could be a promising therapeutic target for melanoma treatment [101].